+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Artificial Cartilage Implant Market by Type, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5967758
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Artificial Cartilage Implant Market grew from USD 118.22 million in 2023 to USD 135.79 million in 2024. It is expected to continue growing at a CAGR of 15.37%, reaching USD 321.69 million by 2030.

Artificial cartilage implants are designed to replicate the function and structure of natural cartilage, primarily used to treat joint disorders like osteoarthritis. The necessity for these implants arises from the high prevalence of joint deterioration among the aging population and athletes, alongside a growing demand for minimally invasive surgical procedures that promise quicker recovery times. Applications extend across various joints, including knees, hips, and hands, with orthopedic clinics and hospitals being the primary end-users. The market scope is significantly defined by advancements in biomaterials science and improved surgical techniques that enhance patient outcomes and increase adoption rates among healthcare providers. Key growth factors include an increased awareness of personalized medicine, escalating incidences of joint injuries, and rising healthcare expenditure in developing regions. Additionally, the integration of 3D printing technology in the production of customized implants presents a substantial opportunity. Despite these prospects, the market faces challenges such as high costs, regulatory hurdles, and limited reimbursement frameworks, which can deter widespread adoption. Addressing these issues requires innovation in cost-effective production methods and fostering collaborations with regulatory bodies for smoother market entry. Advances in material durability and flexibility, as well as the development of surgery-assisting robotic systems, represent pivotal areas for innovation. Engaging in research that refines the biocompatibility and longevity of implants while developing robust post-market surveillance programs could provide a competitive edge. The market is characterized by dynamic competition, with several players focusing on R&D to introduce next-gen solutions. Understanding regional variations in demand, especially in emerging markets with growing healthcare infrastructure, presents lucrative expansion opportunities. In summary, aligning product offerings with evolving clinical needs and regulatory landscapes will be crucial for capturing market share in the rapidly evolving artificial cartilage implant industry.

Understanding Market Dynamics in the Artificial Cartilage Implant Market

The Artificial Cartilage Implant Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing prevalence of osteoarthritis of knee joint and carpometacarpal
    • Rising awareness regarding artificial cartilage implants
    • Growing healthcare expenditure and advanced healthcare facilities
  • Market Restraints
    • High cost associated with the artificial cartilage and replacement surgeries
  • Market Opportunities
    • Technological advancements in implant materials and surgical techniques
    • Development of smart and 3D printing technologies for artificial cartilage implants manufacturing
  • Market Challenges
    • Complications factors associated with artificial cartilage implants

Exploring Porter’s Five Forces for the Artificial Cartilage Implant Market

Porter’s Five Forces framework further strengthens the insights of the Artificial Cartilage Implant Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Artificial Cartilage Implant Market

External macro-environmental factors deeply influence the performance of the Artificial Cartilage Implant Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Artificial Cartilage Implant Market

The Artificial Cartilage Implant Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Artificial Cartilage Implant Market

The Artificial Cartilage Implant Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Artificial Cartilage Implant Market

The Artificial Cartilage Implant Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Artificial Cartilage Implant Market, highlighting leading vendors and their innovative profiles. These include Anika Therapeutics, Inc., BioPoly, LLC, CartiHeal, Inc. by Smith & Nephew PLC, CytoSeek Limited, Medtronic PLC, Narang Medical Limited, NUsurface, Orthox Ltd., Sartorius CellGenix GmbH, Sparta Biomedical Inc., Stryker Corporation, Uteshiya Medicare, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Artificial Cartilage Implant Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type
    • Lower Extremity Joints
    • Upper Extremity Joints
    • Vertebral Joints
  • End-User
    • Ambulatory Surgery Centers
    • Clinics
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of osteoarthritis of knee joint and carpometacarpal
5.1.1.2. Rising awareness regarding artificial cartilage implants
5.1.1.3. Growing healthcare expenditure and advanced healthcare facilities
5.1.2. Restraints
5.1.2.1. High cost associated with the artificial cartilage and replacement surgeries
5.1.3. Opportunities
5.1.3.1. Technological advancements in implant materials and surgical techniques
5.1.3.2. Development of smart and 3D printing technologies for artificial cartilage implants manufacturing
5.1.4. Challenges
5.1.4.1. Complications factors associated with artificial cartilage implants
5.2. Market Segmentation Analysis
5.2.1. Type: Increasing demand for lower extremity joints artificial cartilage implant owing to the high prevalence of osteoarthritis
5.2.2. End-User: Rising demand for artificial cartilage implants in hospitals for extensive patient care facilities
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Artificial Cartilage Implant Market, by Type
6.1. Introduction
6.2. Lower Extremity Joints
6.3. Upper Extremity Joints
6.4. Vertebral Joints
7. Artificial Cartilage Implant Market, by End-User
7.1. Introduction
7.2. Ambulatory Surgery Centers
7.3. Clinics
7.4. Hospitals
8. Americas Artificial Cartilage Implant Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Artificial Cartilage Implant Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Artificial Cartilage Implant Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.3.1. Swiss university launches artificial knee trial backed by USD 13 million
11.3.2. Sparta strengthens patent protection for Ormi implant
11.3.3. CartiHeal Announces First Commercial Implantation of Agili-C in the US
11.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. ARTIFICIAL CARTILAGE IMPLANT MARKET RESEARCH PROCESS
FIGURE 2. ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 9. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. AMERICAS ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 11. AMERICAS ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. UNITED STATES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 13. UNITED STATES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. ASIA-PACIFIC ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ARTIFICIAL CARTILAGE IMPLANT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 19. ARTIFICIAL CARTILAGE IMPLANT MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. ARTIFICIAL CARTILAGE IMPLANT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. ARTIFICIAL CARTILAGE IMPLANT MARKET DYNAMICS
TABLE 7. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY LOWER EXTREMITY JOINTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY UPPER EXTREMITY JOINTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY VERTEBRAL JOINTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 18. ARGENTINA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 19. ARGENTINA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 20. BRAZIL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 21. BRAZIL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 22. CANADA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 23. CANADA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 24. MEXICO ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 25. MEXICO ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 29. ASIA-PACIFIC ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 30. ASIA-PACIFIC ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. ASIA-PACIFIC ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. AUSTRALIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. AUSTRALIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. CHINA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. CHINA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. INDIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. INDIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. INDONESIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. INDONESIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. JAPAN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. JAPAN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. MALAYSIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. MALAYSIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. PHILIPPINES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. PHILIPPINES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. SINGAPORE ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. SINGAPORE ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. SOUTH KOREA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. SOUTH KOREA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. TAIWAN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. TAIWAN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. THAILAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. THAILAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. VIETNAM ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. VIETNAM ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 59. DENMARK ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. DENMARK ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. EGYPT ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. EGYPT ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. FINLAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. FINLAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. FRANCE ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. FRANCE ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. GERMANY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. GERMANY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. ISRAEL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. ISRAEL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. ITALY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. ITALY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. NETHERLANDS ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. NETHERLANDS ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. NIGERIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. NIGERIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. NORWAY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. NORWAY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. POLAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. POLAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. QATAR ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. QATAR ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. RUSSIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. RUSSIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. SAUDI ARABIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. SAUDI ARABIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. SOUTH AFRICA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. SOUTH AFRICA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. SPAIN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. SPAIN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. SWEDEN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. SWEDEN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. SWITZERLAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. SWITZERLAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. TURKEY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. TURKEY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. UNITED ARAB EMIRATES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. ARTIFICIAL CARTILAGE IMPLANT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 102. ARTIFICIAL CARTILAGE IMPLANT MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Artificial Cartilage Implant Market, which are profiled in this report, include:
  • Anika Therapeutics, Inc.
  • BioPoly, LLC
  • CartiHeal, Inc. by Smith & Nephew PLC
  • CytoSeek Limited
  • Medtronic PLC
  • Narang Medical Limited
  • NUsurface
  • Orthox Ltd.
  • Sartorius CellGenix GmbH
  • Sparta Biomedical Inc.
  • Stryker Corporation
  • Uteshiya Medicare
  • Zimmer Biomet Holdings, Inc.

Methodology

Loading
LOADING...

Table Information